STTCOMP LBT TA LONG LBT Innovations SOI 1.3B Mkt Cap A$38m
Announcement yesterday marks critical turnaround for a long suffering and underfunded stock. However, I think the next few weeks and months will see this rerate significantly as sales to pharma are made. With AZ and Thermo Fisher as partners, they are already known to the big end of town, with AZ paying $1m to fund further development points over the past year, that have now been met. AZ have about 6 months of their own internal testing to do but if all goes well there is a real possibility this could be implemented across all AZ's labs.
Chart indicated a base was forming and in the past 2 days has met or exceeded triangle targets. Some settling down here and 3.4 a real resistance area, but volumes suggest to me a turnover of some deadwood, that should set things up nicely for a further move north. This may not occur in the next 8 weeks under the STT comp parameters, but the company has hinted there are several early adopters waiting in the wings and yesterdays announcement may be the catalyst.
The Company's tech could have serious and real cost savings implications for medical facilities around the world. Like all my picks, this could be TA or FA based.
